995 related articles for article (PubMed ID: 21677139)
41. Enzymes that hydrolyze adenine nucleotides in lymphocytes and platelets of immunosuppressed rats.
Saucedo EM; Pereira RS; Barbosa GM; Battisti V; Leal CA; Fleck J; Santos RC; Morsch VM; Schetinger MR; Leal DB
Biomed Pharmacother; 2010 Jul; 64(6):437-40. PubMed ID: 20359849
[TBL] [Abstract][Full Text] [Related]
42. [Immune regulation via the generation of extracellular adenosine by CD73].
Tsukamoto H
Seikagaku; 2014 Dec; 86(6):766-9. PubMed ID: 25675814
[No Abstract] [Full Text] [Related]
43. Deficiency or inhibition of CD73 protects in mild kidney ischemia-reperfusion injury.
Rajakumar SV; Lu B; Crikis S; Robson SC; d'Apice AJ; Cowan PJ; Dwyer KM
Transplantation; 2010 Dec; 90(12):1260-4. PubMed ID: 21063242
[TBL] [Abstract][Full Text] [Related]
44. Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia.
Synnestvedt K; Furuta GT; Comerford KM; Louis N; Karhausen J; Eltzschig HK; Hansen KR; Thompson LF; Colgan SP
J Clin Invest; 2002 Oct; 110(7):993-1002. PubMed ID: 12370277
[TBL] [Abstract][Full Text] [Related]
45. Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence.
Theodoraki MN; Hoffmann TK; Jackson EK; Whiteside TL
Clin Exp Immunol; 2018 Oct; 194(1):67-78. PubMed ID: 30229863
[TBL] [Abstract][Full Text] [Related]
46. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury.
Eckle T; Füllbier L; Wehrmann M; Khoury J; Mittelbronn M; Ibla J; Rosenberger P; Eltzschig HK
J Immunol; 2007 Jun; 178(12):8127-37. PubMed ID: 17548651
[TBL] [Abstract][Full Text] [Related]
47. CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis.
Stagg J; Divisekera U; Duret H; Sparwasser T; Teng MW; Darcy PK; Smyth MJ
Cancer Res; 2011 Apr; 71(8):2892-900. PubMed ID: 21292811
[TBL] [Abstract][Full Text] [Related]
48. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
[TBL] [Abstract][Full Text] [Related]
49. Regulatory T cells from IL-10-deficient mice fail to suppress contact hypersensitivity reactions due to lack of adenosine production.
Ring S; Enk AH; Mahnke K
J Invest Dermatol; 2011 Jul; 131(7):1494-502. PubMed ID: 21430704
[TBL] [Abstract][Full Text] [Related]
50. Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin.
Evans BA; Elford C; Pexa A; Francis K; Hughes AC; Deussen A; Ham J
J Bone Miner Res; 2006 Feb; 21(2):228-36. PubMed ID: 16418778
[TBL] [Abstract][Full Text] [Related]
51. Target tissue ectoenzyme CD39/CD73-expressing Foxp3+ regulatory T cells in patients with psoriasis.
Zhang HY; Yan KX; Huang Q; Ma Y; Fang X; Han L
Clin Exp Dermatol; 2015 Mar; 40(2):182-91. PubMed ID: 25284153
[TBL] [Abstract][Full Text] [Related]
52. CD73 Expressed on γδ T Cells Shapes Their Regulatory Effect in Experimental Autoimmune Uveitis.
Liang D; Zuo A; Zhao R; Shao H; Born WK; O'Brien RL; Kaplan HJ; Sun D
PLoS One; 2016; 11(2):e0150078. PubMed ID: 26919582
[TBL] [Abstract][Full Text] [Related]
53. Activity and expression of ecto-5'-nucleotidase/CD73 are increased during phenotype conversion of a hepatic stellate cell line.
Andrade CM; Roesch GC; Wink MR; Guimarães EL; Souza LF; Jardim FR; Guaragna RM; Bernard EA; Margis R; Borojevic R; Battastini AM; Guma FC
Life Sci; 2008 Jan; 82(1-2):21-9. PubMed ID: 18037449
[TBL] [Abstract][Full Text] [Related]
54. Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease.
Geraghty NJ; Watson D; Sluyter R
Immunol Cell Biol; 2019 Jul; 97(6):597-610. PubMed ID: 30957314
[TBL] [Abstract][Full Text] [Related]
55. Adenosine Generated by Regulatory T Cells Induces CD8
Shi L; Feng M; Du S; Wei X; Song H; Yixin X; Song J; Wenxian G
Biomed Res Int; 2019; 2019():4093214. PubMed ID: 31930120
[TBL] [Abstract][Full Text] [Related]
56. Ecto-5'-nucleotidase (cd73)-dependent and -independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo.
Huang DY; Vallon V; Zimmermann H; Koszalka P; Schrader J; Osswald H
Am J Physiol Renal Physiol; 2006 Aug; 291(2):F282-8. PubMed ID: 16525161
[TBL] [Abstract][Full Text] [Related]
57. Extracellular adenosine enhances the ability of PMNs to kill Streptococcus pneumoniae by inhibiting IL-10 production.
Siwapornchai N; Lee JN; Tchalla EYI; Bhalla M; Yeoh JH; Roggensack SE; Leong JM; Bou Ghanem EN
J Leukoc Biol; 2020 Sep; 108(3):867-882. PubMed ID: 32017200
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation.
Sattler C; Steinsdoerfer M; Offers M; Fischer E; Schierl R; Heseler K; Däubener W; Seissler J
Cell Transplant; 2011; 20(8):1221-30. PubMed ID: 21176405
[TBL] [Abstract][Full Text] [Related]
59. Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.
Mandapathil M; Szczepanski MJ; Szajnik M; Ren J; Lenzner DE; Jackson EK; Gorelik E; Lang S; Johnson JT; Whiteside TL
Clin Cancer Res; 2009 Oct; 15(20):6348-57. PubMed ID: 19825957
[TBL] [Abstract][Full Text] [Related]
60. A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.
Kaku H; Cheng KF; Al-Abed Y; Rothstein TL
J Immunol; 2014 Dec; 193(12):5904-13. PubMed ID: 25392527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
